Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 10:35, 24 June 2024 EProba talk contribs created page Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (Created page with "{{Reference |Reference=Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer }} =Brief summary= In this dose-escalating study, some participants were initially given 400mg EGCG (in the form of polyphenon E capsules) twice a day. As soon as someone reported a severe side effect (grade II according to CTCAE), it was looked at again and calculated how likely it was...")